Double-blind comparison of fluoxetine versus clomipramine in the treatment of obsessive compulsive disorder

By Lopez-Ibor J.J.   Saiz J.   Cottraux J.   Note I.   Vinas R.   Bourgeois M.   Hernandez M.   Gomez-Perez J.C.  

European Neuropsychopharmacology, Vol. 6, Iss. 2, 1996-05 ,pp. : 111-118

Elsevier

Access to resources Recommend Favorite

New Statistical Proposals to Evaluate the Benefit/Risk Ratio of Long-Term Treatment of Depression: Application to a One-Year Double-Blind Study Comparing Medifoxamine with Fluoxetine

By Lehert P.  

Clinical Drug Investigation, Vol. 15, Iss. 4, 1998-04 ,pp. : 285-295

Adis International

Access to resources Recommend Favorite

A double-blind, multicentre study in primary care comparing paroxetine and clomipramine in patients with depression with associated anxiety

By Hunter B.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 309-309

Elsevier

Access to resources Recommend Favorite

The treatment of dysthymia with sertraline: a double-blind placebo-controlled trial in dysthymic outpatients without major depression

By Guelfi J.D.   Wiseman R.L.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 289-290

Elsevier

Access to resources Recommend Favorite

A randomized, placebo-controlled, double-blind trial of sertraline for postpartum depression

By Hantsoo Liisa   Ward-O’Brien Deborah   Czarkowski Kathryn   Gueorguieva Ralitza   Price Lawrence   Epperson C.  

Psychopharmacology, Vol. 231, Iss. 5, 2014-03 ,pp. : 939-948

Springer Publishing Company

Access to resources Recommend Favorite